BIOMARIN PHARMACEUTICAL INC: net_income
| Value | {"amount": 854029000, "concept": "us-gaap:NetIncomeLoss", "currency": "USD"} |
|---|---|
| Period | 2020-01-01 – 2020-12-31 |
| Status | current |
| Entity | BIOMARIN PHARMACEUTICAL INC |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T10:17:13.171852+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/32c254c5-8c5e-4a58-8431-f189fb176c18
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001048477-23-000009Retrieved: 2026-08-19T10:17:13.171852+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001048477/net-income/2020-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/32c254c5-8c5e-4a58-8431-f189fb176c18
History
- supersedes {"amount": 859100000, "concept": "us-gaap:NetIncomeLoss", "currency": "USD"} (evidence 0001048477-21-000008)